BIOMAT Database Logo BIOMAT Database Logo

Chemotherapy of leukemia L1210 by 6-mercaptopurine (NSC-755) in combination with 6-methylthiopurine ribonucleoside (NSC-40774). 1967

F M Schabel, and W R Laster, and H E Skipper

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000963 Antimetabolites Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) Antimetabolite
D015122 Mercaptopurine An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. 6-Mercaptopurine,1,7-Dihydro-6H-purine-6-thione,6-Mercaptopurine Monohydrate,6-Thiohypoxanthine,6-Thiopurine,6H-Purine-6-thione, 1,7-dihydro-,BW 57-323H,Leupurin,Mecaptopurine Anhydrous,Mercaptopurina Wellcome,Puri-Nethol,Purimethol,Purinethol,6 Mercaptopurine,6 Mercaptopurine Monohydrate,6 Thiohypoxanthine,6 Thiopurine,BW 57 323H,BW 57323H
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

F M Schabel, and W R Laster, and H E Skipper
Combinations of 6-mercaptopurine (NSC-755) and 6-(methylmercapto)purine ribonucleoside (NSC-40774) in therapy of Ehrlich ascites carcinoma.
June 1967, Cancer chemotherapy reports,
F M Schabel, and W R Laster, and H E Skipper
Studies of combination 6-mercaptopurine (NSC-755) and 6-methylmercaptopurine riboside (NSC-40774) in patients with acute leukemia and metastatic cancer.
February 1968, Cancer chemotherapy reports,
F M Schabel, and W R Laster, and H E Skipper
COMBINATION OF METHYLGLYOXAL BIS(GUANYLHYDRAZONE) (NSC-32946)AND 6-MERCAPTOPURINE (NSC-755) IN ACUTE GRANULOCYTIC LEUKEMIA.
April 1965, Cancer chemotherapy reports,
F M Schabel, and W R Laster, and H E Skipper
COMPARATIVE CLINICAL TOXICITY OF 6-MERCAPTOPURINE (NSC-755)-1 AND 6-MERCAPTOPURINE RIBONUCLEOSIDE (NSC-4911)-2 ADMINISTERED INTRAVENOUSLY TO PATIENTS WITH ADVANCED CANCER.
March 1964, Cancer chemotherapy reports,
F M Schabel, and W R Laster, and H E Skipper
Clinical pharmacologic observations on 6-mercaptopurine and 6-methylthiopurine ribonucleoside.
January 1968, Clinical pharmacology and therapeutics,
F M Schabel, and W R Laster, and H E Skipper
Drug trials in neuroblastoma: cyclophosphamide (NSC-26271) alone; vincristine (NSC-67574) plus cyclophosphamide; 6-mercaptopurine (NSC-755) plus 6-methylmercaptopurine riboside (NSC-40774); and cytosine arabinoside (NSC-63878) alone.
January 1974, Cancer chemotherapy reports,
F M Schabel, and W R Laster, and H E Skipper
Spleen colony studies of leukemia L1210. 3. Differential sensitivities of normal hematopoietic and resistant L1210 colony-forming cells to 6-mercaptopurine (NSC-755).
February 1968, Cancer chemotherapy reports,
F M Schabel, and W R Laster, and H E Skipper
Combination therapy with 6-mercaptopurine (NSC-755) and allopurinol (NSC-1390) during induction and maintenance of remission of acute leukemia in children.
February 1969, Cancer chemotherapy reports,
F M Schabel, and W R Laster, and H E Skipper
Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemia.
August 1972, Cancer chemotherapy reports,
F M Schabel, and W R Laster, and H E Skipper
ENHANCEMENT OF ANTILEUKEMIC ACTION IN MICE OF 6-MERCAPTOPURINE (NSC-755) BY URETHAN (NSC-746).
July 1964, Cancer chemotherapy reports,
Copied contents to your clipboard!